The Otolaryngologic Clinics of North America 2000: Vol 33 Index

23 Pages·2000·4.7 MB·English

CUMULATIVE INDEX 2000
Volume 33
February UPDATE ON THE PEDIATRIC AIRWAY, pages 1-226
April FUNGAL RHINOSINUSITIS: A SPECTRUM OF DISEASE, pages
227-454
June PRACTICAL ISSUES IN THE MANAGEMENT OF THE DIZZY
AND BALANCE DISORDER PATIENT, pages 455-677
August VOICE DISORDERS AND PHONOSURGERY I, pages 679-921
October VOICE DISORDERS AND PHONOSURGERY II, pages 923-1157
December SYNDROMIC AND OTHE. CONGENITAL ANOMALIES OF
THE HEAD AND NECK, pages 1159-1417
Note: Page numbers of article titles are in boldface type
Accent method, to treat dysphonias, 996 Agoraphobia, dizziness in, 605-606
Achondroplasia, obstructive sleep apnea Airflow, phonation, in dysphonia, 734-735
in, 70 Airway, hemangiomas and vascular
Acidification tests, to diagnose malformations of, 209-220
gastroesophageal reflux, 154 major, collapse of, management of, 163-
Acoustic analysis, in dysphonia, 737-741 177
Acoustic neuroma, 478, 545, 597 management of, in micrognathia, 1186
Acquired immunodeficiency syndrome, in space-occupying oropharyngeal le-
fungal invasive sinusitis in. See sions, 1172
Sinusitis, fungal, invasive, in acquired obstruction of, in Pierre Robin syn-
immunodeficiency syndrome. drome, 1245-1252
Activities of daily living scale, to assess in recurrent respiratory papillo-
outcome of dizziness treatment, 524 matosis, 194
Activities specific balance confidence scale, pediatric, endoscopy of, anesthesia for,
to assess outcome of dizziness 9-4
treatment, 522-523 diagnosis using, 32
Acyclovir, in juvenile onset recurrent management of, history of, 1-14
respiratory papillomatosis, 200 radiologic evaluation of, new tech-
in recurrent respiratory papillomavirus, niques for, 15
1139 radiology of, advances in, 15-28
Adenoid facies, and pediatric obstructive update on, 1-220
sleep apnea syndrome, 51-52 structural anomalies of, in velocardiofa-
Adenoidectomy, in pediatric obstructive cial syndrome, 1226-1230
sleep apnea syndrome, 66-68 upper, obstruction of, spontaneous respi-
Adenotonsillar hypertrophy, and pediatric ratory inhalation technique for anes-
obstructive sleep apnea syndrome, thesia for, 41-43
51-52 Alcohol abuse, vocal technique and, 938
Aerodynamic analysis, in dysphonia, Allergic disease, in vocal performers, 959
734-737 Alpha interferons, in juvenile onset
Age, as influence on posture and gait, recurrent respiratory papillomatosis,
650-653 200-201
1395
1396 CUMULATIVE INDEX 2000
Alport’s syndrome, hearing impairment in, Anxiety, with dizziness, 668
1381 Aortopexy, in tracheobronchomalacia,
Alternative medications, effects on voice, 163-164, 167, 168-169
782 Apert’s syndrome, 1258-1263
American Academy of Ophthalmology birth prevalence and genetics of, 1259
and Otolaryngology, 1 central nervous system in, 1259-1261
American Academy of Pediatrics, cranial vault in, 1259, 1260-1261
Otolaryngology and midface features in, 1261-1262
Bronchesophagologic Section of, 13 ocular findings in, 1262
American Society of Pediatric syndactyly in, 1262-1263
Otolaryngology, 13 Apneic attacks, mechanisms of, 31
Ames, Mary, 9 Amold-Chiari malformation, 588
Amphotericin B, 305-306, 331, 363, 384, bilateral vocal fold immobility in, 860
403 vocal cord paralysis in, 140-141
lipid-based formulations of, 283-284 Artery(ies), innominate, compression of,
Amphotericin B deoxycholate, 279-283 endoscopic diagnosis of, 24, 25
Amyotrophic lateral sclerosis, bilateral Arytenoid adduction, 832-836
vocal fold immobility in, 860-861 and medialization laryngoplasty, 817—
Analgesics, dysphonia associated with,
839
776-777 anesthesia for, 833
Anesthesia, and endoscopy, in pediatric biomechanics of, 824-829
patients, complications of, 46
preoperative preparation for, 832-833
endoscopic equipment and, 33
removal of posterior thyroid lamina for,
for arytenoid adduction, 832-833
834
for medialization laryngoplasty, 829-830
surgical exposure for, 833-834
for pediatric airway endoscopy, 29-47
Arytenopexy, adduction, in paralytic
requirements for, 29-30
dysphonia, 849-851
general, in pediatric patient, preparation
Aspergillosis, allergic bronchopulmonary,
for, 33-34
problems during, 35 399-400, 409, 419
requirements for, 34 stages of, 400
heat conservation during, 31 recurrent, antifungal agents to prevent,
local, supplementary, for pediatric pa- 307-309
tient, 35 sinus. See Sinusitis, fungal, invasive.
Anesthesiology, and otorhinolaryngology, triazoles in, 289
29-30 Auricle, surgical repair of, in microtia
Anesthetic techniques, classification of, atresia, 1356-1369
35-36 Autoimmune disorders, dysphonia
commonly used, 36-37 associated with, 724
Antibiotics, in fungal allergic Autoimmune inner ear disease, 553-556
rhinosinusitis, 429-430 organ specific, 554
Antidepressants, dysphonia associated Axiolytics, complications of, 781
with, 779-780 Azoles, 284-289
in dizziness and psychopathology, 630-
631
Antifungal therapy, antifungal drugs in,
279-292 Bacteriology and mycology laboratories,
future directions in, 292-293 examination of fungal rhinosinusitis
in fungal allergic rhinosinusitis, 423 specimens in, 256-259
principles of, 279 Balance function testing, 507-517
prophylactic, in invasive fungal sinusi- application of, 515-517
tis, 304-307 information provided by, 508-509
in prevention of fungal sinusitis, 304— Balance function tests, accuracy of,
307 interpretation and, 508
resistance to, strategies to overcome, 279 Balance system, anatomy and operational
Antihistamines, dysphonia associated physiology of, 455-467
with, 772-773 functional operation of, in daily activi-
Antihypertensive agents, dysphonia ties, 455-469
associated with, 775 Balloon dilation, of tracheobronchial
Antipsychotic drugs, complications of, stenoses, 23-26
781-782 Barium swallow, modified, 19
CUMULATIVE INDEX 2000 1397
feeding during, 20 normal developmental anatomy of,
silent aspiration on, 19, 20 1309-1313
Barotrauma, to inner ear, hearing loss in, Branchial arch remnants, 1313, 1314
539-541 Branchial cleft, cysts of, 1318-1320
Basement membrane zone, of vocal cords, first, anomalies of, 1315-1318
683-684, 685, 686 second, anomalies of, 1318-1322
Beckwith-Wiedemann syndrome, 1183, sinuses and fistulas of, 1320, 1321-
1184 1322
Bedside vestibular examination, 495-506 Branchial pouch, second, anomalies of,
Bedtime behavior problems, in pediatric 1318-1322
obstructive sleep apnea syndrome, third and fourth, anomalies of, 1322-
53-54 1326
Benign paroxysmal positional vertigo. See Branchio-oto-renal syndrome, branchial
Vertigo, benign paroxysmal positional. apparatus anomalies in, 1329
Benzodiazepines, in dizziness and hearing impairment in, 1381
psychopathology, 629-630 Breathiness, causes of, 925-926
Bifid epiglottis, congenital, 94-95 definition of, 925
Biopsy, nasal, in invasive fungal Breathing disorders, laryngeal,
rhinosinusitis, 328-329 neurolaryngology and, 898
Birth trauma, to head and neck, 1176-1178 Bronchitis, arachidic, 180
Blastomycosis, triazoles in, 288 Bronchoactive medications, dysphonia
B-Blockers, dysphonia associated with, 778 associated with, 778
Bluestone, Charles D., MD, 2, 9-10, 13 Bronchoscopy, flexible, diagnostic, 32
Bone marrow transplants, prophylactic Bronchus(i), stenosis of, therapeutic
antifungal agents in, 304-309 radiology in, 22-26
Botulinum toxin, antibody formation and, Brunings, Wilhelm, 809-810
884 Buckingham, Richard, MD, 9
contraindications to use to, 884
for treatment of spasmodic dysphonia,
879-894 Canalith repositioning procedure, 570
inhibition of neurotransmitter release
Canalithiasis, 565, 566
and, 882-883
Candida albicans, triazoles in, 288
injections of, rating criteria for, 886
Candidiasis, sinusitis and, 261-262, 263
results of, 891-892
Carbon dioxide laser, in
technique of, 886-889 phonomicrosurgery, 1052, 1064-1065
treatment and dosing in, 889-891 Carbon dioxide laser surgery, in recurrent
pharmacology of, 881
respiratory papillomavirus, 1136
preparation and toxicity of, 883-884 Cardiovascular anomalies, as cause of
usage during pregnancy, 884 vocal cord paralysis, 136-137
usage in children, 884 Cardiovascular medications, in dizziness
Botulinum toxin A, in posterior glottic and psychopathology, 628-629
stenosis, 872 Cardiovascular syncope, as cause of falls
Brain, vascular malformations in, and and gait unsteadiness, 639
hemorrhage, vertigo in, 596 Carpenter’s syndrome, 1270
Brainstem diseases, as cause of falls and Central nervous system, abnormalities of,
gait unsteadiness, 641-642 obstructive sleep apnea in, 70
Brainstem gliomas, central vertigo in, anomalies of, vocal cord paralysis in,
596-598 134-135
Branchial apparatus, anomalies of, lesion of, causing gait abnormalities,
1313-1326 647-648
in branchio-oto-renal syndrome, 1329 Cerebellar disease, cerebellar signs of, 586
in DiGeorge anomaly, 1327 spinocerebellar atrophy in, 587-588
in Goldenhar’s syndrome, 1328 Cerebellar disorders, dizziness in, physical
in hemifacial microsomia, 1328-1329 therapy in, 668
in Pierre Robin sequence, 1327-1328 Cerebellar infarction, central vertigo in,
in Treacher Collins syndrome, 595-596
1326-1327 Cerebrovascular accident, bilateral vocal
cysts of, 1313-1315 fold immobility in, 861
head and neck anomalies related to, Challenge voice therapy, caveats and
1309-1332 expectations for, 994
1398 CUMULATIVE INDEX 2000
Challenge voice therapy (Continued) pathophysiology of, 1338-1339
description and rationale for, 993-994 sinusitis and otitis media in, 1339-1340
CHARGE, 1178, 1344, 1349 Circumlaryngeal massage, manual, caveats
choanal atresia, and congenital stenosis, and expectations for, 990
1343-1351 description and rationale for, 989
Chewing method, to treat dysphonias, therapy protocol for, 989-990
996-997 Cis-retinoic acid, in juvenile onset
Child(ren), bilateral immobility of vocal recurrent respiratory papillomatosis,
folds in, treatment of, 872 201-202
dysphonia in, behavioral management Cleft lip, anatomy of, 1196-1197
of, 1097-1109 and cleft palate, 1183-1185, 1191-1215
posterior glottic stenosis in, treatment classification of, 1193-1194
of, 872 epidemiology of, 1194-1195
use of botulinum toxin in, 884 etiology and genetics of, 1195-1196
vocal-fold cysts in, 1102, 1117, 1118 nonsyndromic, familial risks for, 1196
vocal-fold edema in, 1100 bilateral, anatomy of, 1202-1203
vocal-fold polyps in, 1102 management of premaxilla in, 1203
vocal nodules in, 1100-1102, 1116-1117 surgical technique in, history of, 1203
Chmielik, Professor Mieczyslaw, 7 repair of, 1203-1205
Choanal atresia, 1178-1179 surgery in, postoperative care in, 1202
bilateral, symptoms of, 78 primary nasal correction in, 1202
CHARGE association, and congenital ste- rotation-advancement technique in,
nosis, 1343-1351 1198, 1199
clinical presentation of, 1344 markings for, 1199-1200
complications of, 1348-1349 points for, 1200-1201
congenital, theories explaining develop- techniques of, history of, 1197-1198
timing of, 1197
ment of, 77-78
congenital anomalies associated with, 78 to repair orbicularis oris, 1201-1202
embryology of, and anatomy of nose, Cleft palate. See also Cleft lip, and cleft
1343-1344 palate.
endoscopic and powered instrumenta- anatomy of, 1206-1207
tion for, 84-86 in velocardiofacial syndrome, 1222-1224
presurgical orthopedic management in,
endoscopic versus traditional ap-
proaches to, 77-90 1207
epidemiology of, 1344 primary gingivoperiosteoplasty in, 1207
in computed tomography, 78 repair of, in Pierre Robin sequence, 1252
surgical technique for, 1208-1211, 1212
laser repair of, 1348
timing of, 1207-1208
laser treatment of, 79-80
sequelae of, 1205-1206
management of, 1345-1346
Clotrimazole, 287
microscopic drill-out procedure in, 83,
Coccidiomycosis, triazoles in, 288-289
84
Cogan’s syndrome, 554
neonatal bilateral bony, 79 Cognitive-behavior therapy, in dizziness
postoperative care in, 87-88 and psychopathology, 631-632
sublabial transeptal repair of, 86, 87 Cognitive function, in pediatric obstructive
surgical approaches to, 1346-1348 sleep apnea syndrome, 54
transnasal puncture technique in, 79-80, Cohen, Eli, 7-8
81 Cohen, Harold, 7-8
transpalatal repair in, 81-83 Cohen, Seymore, MD, 7-8, 13
treatment of, ideal procedure for, 78-79 Collagen injection, for vocal-fold injection,
Chromoblastomycosis, sinusitis and, 260, 1090
262-263 in vocal-fold scar, 1084-1085
Cidofovir, in recurrent respiratory Computed tomography, advantages of, 21
papillomavirus, 1139-1140 controlled ventilation, in children, 21-22,
injection of, in juvenile onset recurrent 23
respiratory papillomatosis, 201 spiral, 22, 24
Cigarette smoking, voice problems electron beam, 21
associated with, 971 in choanal atresia, 78
Ciliary dyskinesia, and cystic fibrosis, in subglottic hemangioma, 211-212
head and neck manifestations of, in suspected invasive fungal rhinosinus-
1333-1342 itis, 326-327
CUMULATIVE INDEX 2000 1399
in vascular malformations, 215 ocular findings in, 1265-1266
ultrafast, 21 Cryptococcosis, sinusitis and, 260, 264
in obstructive sleep apnea, 17-18 Cryptococcus, triazoles in, 288
Computerized dynamic posturography Culture identification, in mycotic
test, to assess outcome of dizziness infections, 245
treatment, 526-527 Cuneiform cartilage, anomalous, 96
Computerized dynamic visual acuity, to Cupulolithiasis, 565
assess outcome of dizziness treatment, Cystic fibrosis, and ciliary dyskinesia,
525-526 head and neck manifestations of,
Confidential voice, caveats and 1333-1342
expectations for, 987 clinical manifestations of, 1334-1335
description and rationale for, 985-986 pathophysiology of, 1333-1334
therapy protocol for, 986-987 sinusitis in, 1335-1338
Conidiobolomycosis, sinusitis and, 263, Cystic hygroma, 1179-1180
264 Cysts, saccular, 95-96, 1118
Conversion dysphonia, 1038-1039 vocal-fold, 1040-1041
Coordination, assessment of, for treatment in child, 1102, 1117, 1118
of dysphonia, 1006-1007
Cordotomy, lateral, in vocal-fold scar, 1085
Corticosteroids, dysphonia associated
with, 773-774 Danielewicz, Jan Gabriel, MD, 5-7
Cotton, Robin T., MD, 10 Deafness. See Hearing loss.
Craniofacial disorders, classes of, Dental disorders, in professional singers,
1161-1166 932-933
genetic counseling in, 1166 Depression, dizziness in, 607
genetic evaluation in, 1160-1161 Diabetes mellitus, bilateral vocal fold
in velocardiofacial syndrome, 1219-1224 immobility in, 860
obstructive sleep apnea in, 70 Diet, effect of, on vocal production, 971
secretory proteins and, 1165-1166 DiGeorge anomaly, branchial apparatus
transcription factors and, 1161-1163 anomalies in, 1327
transmembrane proteins and, 1163-1165 Diindolylmethane, in juvenile onset
Craniosynostosis, 1175-1176, 1257-1258 recurrent respiratory papillomatosis,
and midface hypoplasia, syndromes in- 199-200
volving, 1257-1284 Diphtheria, 3-5
treatment of, 1270-1281 Diphtheria antitoxin, 4-5
for patients 9 months to 3 years old, Disability index, to assess outcome of
1274 dizziness treatment, 523-524
for patients 6 to 9 months old, Diuretics, dysphonia associated with, 774
1272-1274 Dizziness, and imbalance, psychologic
for patients 3 to 5 years old, 1274— symptoms and psychiatric disorders
1276 in, diagnosis and treatment of,
for patients in adolescence or adult- 617-635
hood, 1277-1281 and psychologic disturbance, comorbid-
for patients under 6 months old, ity between, 603-605
1271-1272 symptoms of, 605
Cri du chat syndrome, 98 vicious cycle of, 608-610
Cricoarytenoid joint, pathologic conditions and psychopathology, clinical presenta-
of, 1042 tion in, 619-620
Cricothyroid membrane, in neonate, 30 course of illness in, 622-624
Cricothyroid subluxation, in paralytic differential diagnosis of, 620-622
dysphonia, 851-852 fear response in, 623
Cricothyroid visor, palpation of, 1028-1029 mood state in, 623-624
Croup, spontaneous respiration inhalation symptom focus in, 623
technique for anesthesia and treatment of, 627-632
intubation in, 43-44 central, vestibular therapy in, 669
Crouzon’s syndrome, birth prevalence and central causes of, 665-668
genetics of, 1263-1264 chronic, and balance disorders, preven-
central nervous system in, 1264 tion of negative reactions to, 610-
cranial vault in, 1264 613
midface features in, 1264-1265 psychologic effects of, 603-616
1400 CUMULATINIDEXV E20 00
Dizziness (Continued) aerodynamic analysis in, 734-737
definitions of, 472 assessment of clarity of speech in, 1010
diagnostic vestibular groups for special assessment of filter control and flexibil-
consideration in, 666 ity in, 1008-1010
hypoglycemic, 581 assessment of repertoire and perfor-
in cerebellar disorders, physical therapy mance/ rehearsal schedule in, 1011-
in, 668 1012
in drug toxicity, 581 assessment of source control and flexibil-
in head injury, management of, 667 ity in, 1008
in medical or psychiatric illness, 624-625 associated with analgesics, 776-777
in panic and agoraphobia, 605-606 associated with antihistamines, 772-773
in postconcussion syndrome, 581 associated with antihypertensive agents,
management of, assessment of psy- 775
chologic disturbance in, 610-611 associated with B-blockers, 778
Medical-Psychiatric Interaction Model of associated with bronchoactive medica-
symptom development in, 622 tions, 778
medical-psychiatric interactions in, 624- associated with corticosteroids, 773-774
626 associated with diuretics, 774
panic and anxiety symptoms with, 668 associated with edema medications, 774—
presyncopal, causes of, 580-582 775
psychogenic, 626 associated with gastroenterologic medi-
psychophysiologic, 581 cations, 775-776
symptoms of, duration of, 476-479 associated with hormones, 777-778
synonyms for, 472 associated with mucolytic agents, 773
Dizziness handicap inventory, to assess associated with neurologic medications,
outcome of dizziness treatment,
778-779
521-522 associated with psychoactive medica-
Dizzy and balance disorder patient,
tions, 779-782
management of, 455-672
basic assessment protocol in, criteria for,
outcome measures of, 519-533
747-748
correlation between, 528-531
conversion, 1038-1039
physical, 525-528
database management in, 748
self-report, 521-525
definition of, 925, 945
types of, 520-528
efficiency of phonation in, 737
DNA, mitochondrial, abnormalities of,
electroglottography in, 741-742, 743-744
hearing impairment in, 1373
Down syndrome, obstructive sleep apnea electromyography in, 747
in, 69-70, 1289-1290 evaluation of, medical and vocal history
orofacial manifestations of, 1285-1286, in, 719-729
1287 exacerbating and ameliorating factors in,
otolaryngologic manifestations of, 1285- 721
1292 flow glottography in, 735
otologic disorders in, 1290-1291 flow-versus-volume loops in, 735-737
upper airway in, 1286-1289 glottographic techniques in, 741-744
Downs, Jack, MD, 11 history of present illness in, 719-721
Dumon stent, in major airway collapse, impairment, disability, and other medi-
173-174 cal-legal aspects of, 1143-1152
Dynamic posturography, 514-515 inciting factors in, 720-721
Dysarthria, definition of, 945 methods of voice therapy in, 983-1002
hyperkinetic, 945 muscle-tension, 1037-1038
mixed, 946 occupational history in, 727-728
Dysequilibrium, multisensory, and paralytic, adduction arytenopexy in,
vestibular dysfunction, in older 849-851
adults, 664-665 assessment and treatment of, evolu-
vertigo and, with hearing loss, 535-562 tion of, 803
Dysphagia, neurolaryngology and, 902 cricothyroid subluxation in, 851-852
Dysphonia(s), abductor spasmodic, Goretex medialization in, 851
botulinum toxin injection in, 888-889 new procedures for, 841-853
acoustic analysis in, 737-741 surgical technique in, 843-849
adductor spasmodic, botulinum toxin in- independent parameters for, 849
jection in, 886, 887 past medical history in, 722-725
CUMULATIVE INDEX 2000 1401
past surgical history in, 726 assessments for, 1004-1005
pediatric, anatomic causes of, 1116-1117 videolaryngostroboscopy in, 733-734
behavioral management of, 1097-1109 voice and speech material in, 732-733
causes of, 1111-1112 Dysphonia indexes, 746-747
congenital causes of, 1117 Dystonia, genetics of, 880-881
diagnosis of, 1098-1100
differential diagnosis and treatment
of, 1115-1122
evaluation of, 1112-1115 Ear, external, repair of, in microtia atresia,
gastropharyngeal reflux associated psychologic issues in, 1356
with, 1113 external and middle, congenital anoma-
history taking in, 1112-1113 lies of, 1315
iatrogenic causes of, 1122 inner, acquired malformations of, 537-
laryngeal pathologic conditions re- 542
lated to, 1100-1103 barotrauma to, hearing loss in, 539-
medical and surgical treatment of, 541
1111-1125 chemical ototoxicity causing hearing
microlaryngoscopy in, 1115 loss and imbalance in, 552-553
neoplastic causes of, 1119-1120 congenital malformations of, 535-537
neurologic causes of, 1120-1122 idiopathic disorders of, 556-558
physical examination in, 1113-1114 immunologic conditions involving,
voice evaluation in, 1103-1104 553-556
voice therapy in, progress reports in, infectious lesions of, 548-550
1106 metabolic malformations of, 542-544
techniques for, 1107-1108 neoplastic lesions of, 545-547
versus in adults, 1104-1108 perilymph fistula of, hearing loss in,
vocal hygiene in, 1106 541-542
perceptual analysis of, 733 syphilis involving, 550-552
perpetual and laboratory assessment of, trauma to temporal bone of, hearing
731-750 loss in, 537-539
phonation airflow in, 734-735 malformations of, in velocardiofacial syn-
phonatory onset of, approaches to, 994— drome, 1225-1226
996 of professional singers, examination of,
phonetography or voice-range profile in, 941
744, 745 Echinocandins, 293
photoglottography in, 742 Edema, medications for, dysphonia
recording voice sample in, 732 associated with, 774-775
reflexmyography in, 747 Electroglottography, in dysphonia,
related to medical therapy, 771-784 741-742, 743-744
related to posture, 1023-1024 Electromyography, basics of, 759-760
review of systems in, 721-722 in dysphonia, 747
rhinophonia measurement in, 744-746 laryngeal, 759-770
self-evaluation in, 746 administration and interpretation of,
social history in, 726-727 761-763
spasmodic, 1043 findings of, interpretation and classifi-
diagnosis of, 885-886 cation of, 764-766
history of, 879-880 in bilateral immobility of vocal folds,
neurolaryngology and, 898, 900 863
subglottal air pressure in, 737 indications for, 760-761
time course of, 721 observed, temporal rela‘ionships with,
treatment of, application of singing tech- 763-764
niques in, 1003-1015 prognosis with, 766-769
assessment of coordination in, 1006— Electronystagmography, 509-510
1007 caloric testing in, 513
assessment of posture and athleticism oculomotor evaluation in, 510-511
for, 1005 positional testing in, 512-513
assessment of quality of voice in, spontaneous and gaze-evoked nystag-
1010-1011 mus in, 511-512
assessment of respiratory control and Elsberg, Louis, 804, 805
flexibility in, 1007-1008 Elsner, John, MD, 3
1402 CUMULATIVE INDEX 2000
Emotional stimuli, as cause of syncope Extracellular matrix, of vocal cords,
and falls, 642 composition of, 688-692
Encephalocele, formation of, following regulation of, 692-693, 694
surgery in fungal allergic
rhinosinusitis, 415, 416, 417
Endocrine abnormalities, dysphonia
associated with, 724-725 Face, embryology of, 1192
Endocrine dysfunction, in professional Fall prevention program, for elderly, 652
Falls, and neurologic disorders in elderly,
singers, 934-935
650-651
Endoscopes, in pediatric bronchoscopy,
causes of, 638-642
development of, 11-12
idiopathic, 642
Endoscopic equipment, and anesthesia, 33
unexplained, and gait unsteadiness, as-
Endoscopic laryngeal surgery, origin and
development of, 1047-1049 sessment of, 637-657
Fat, autologous, for vocal-fold injection,
Endoscopy, and powered instrumentation,
1089-1090, 1094
for choanal atresia, 84-86
Fearson, Blair, MD, 8, 10
anesthesia and, in pediatric patients,
Ferguson, Charles, MD, 7, 9, 12
complications of, 46
Fetal alcohol syndrome, in Pierre Robin
diagnostic, spontaneous respiration inha-
syndrome, 1254
lation technique for. See Spontaneous
Fibrin glue, in subglottic stenosis, 125
respiration inhalation technique. Fibroblast growth factor level, basic, test
esophageal, in gastroesophageal reflux, of, in subglottic hemangioma, 212
790 Fibroblast growth factor receptors,
flexible fiberoptic, 32-33 1163-1165
laryngeal, diagnostic, 751-757 Flake, Carlyle, MD, 7, 9, 12
pediatric airway, anesthesia for, 29-47 Flexible fiberoptic endoscopy, 32-33
rigid, 753-755 Flow glottography, in dysphonia, 735
in examination of professional singers, Flow-versus-volume loops, in dysphonia,
943 735-737
transnasal flexible, 752-753 Fluconazole, 288, 304-305
versus traditional approaches to choanal Flucytosine, 290-291
atresia, 77-90 Fluid intake, effect of, on vocal
Enuresis, in pediatric obstructive sleep production, 971
apnea syndrome, 54-55 Fluoroscopy, airway, advantages of, 16, 18
Environmental factors, as cause of syncope in foreign body diagnosis, 16
and falls, 642 in synchronous airway lesions, 16
Environmental pollution, professional in upper airway obstruction, 16
singers and, 937 sleep, in pediatric upper airway obstruc-
Epidermis, of vocal cords, 680-683 tion, 17
Epiglottis, congenital bifid, 94-95 Foods, affecting voice, 939
Epiglottitis, acute, spontaneous respiration Foreign body(ies), aspirated,
inhalation technique for anesthesia bronchoscopic removal of, spiral
and intubation in, 44 computed tomography following, 24
as cause of pediatric dysphonia, 1116 diagnosis of, fluoroscopy in, 16
Epiglottoplasty, in laryngomalacia, 94 esophageal, ingestions of, clinical presen-
Epignathus, 1172 tation of, 183-184
Epilepsy, as cause of falls and gait complications of, 184-185
unsteadiness, 639-640 diagnostic imaging in, 184
Epileptic vertigo, 598-599 retrieval techniques in, 184
Esophagogastroduodenoscopy, with inhaled, removal of, spontaneous respira-
biopsy, to diagnose gastroesophageal tory inhalation technique for anes-
reflux, 153 thesia for, 44-46
Esophagram, barium, to diagnose tracheobronchial, 179-185
gastroesophageal reflux, 153 ingestions of, clinical presentation of,
Exercise(s), for vocal disorders, 1012-1014 179-180
habituation, in benign paroxysmal posi- complications of, 182-183
tional vertigo, 571-572 diagnostic imaging in, 181, 182
in vestibular rehabilitation, 661-662 retrieval techniques in, 181-182
vocal, 972-973 Fundoplication, in gastroesophageal reflux,
vocal function, 990-991 158-159
CUMULATIVE INDEX 2000 1403
Fungal antigens, commercially available, manifestations of, 156-157
401, 402 medical treatment of, 157-158, 159
in allergic fungal sinusitis, positive re- surgical treatment of, 158-159
sponses to, 434 as cause of pediatric dysphonia, 1118-
Fungal cultures, interpretation of, 230-231 1119
Fungal disease(s), concepts of, 242-243 classification of, 151-152
of sinuses, diagnosis of, 255 definition of, 785
Fungal infections. See Infection, fungal. diagnosis of, 152-156
Fungal infestation, saprophytic, 232 evaluation of, in subglottic stenosis, 115—
Fungal panallergen, 428 116
Fungal rhinosinusitis. See Rhinosinusitis, guidelines to reduce, 976
fungal. of professional singers, 933
Fungus balls, 231, 353, 376 pathophysiology of, 152
in paranasal sinuses, 389-398 posterior glottic stenosis in, 859
age, sex, and cultured fungus from, problems of, 970-971
390 Gastrointestinal disorders, dysphonia
clinical presentation of, 391 associated with, 723
epidemiology of, 390-391 Gastrolaryngopharyngeal reflux,
fungal cultures of, 393-394 evaluation of, in subglottic stenosis,
histopathology of, 392-393 115-116
immunology of, 394 Gastropharyngeal reflux, associated with
location of, 394 pediatric dysphonia, 1113
pathogenesis of, 394-395 Gelatin sponge, for vocal-fold injection,
radiography of, 391, 392 1089
special considerations in, 396, 397 Genetic counseling, in craniofacial
treatment of, 395-396
disorders, 1166
Fungus(i), and fungal infections, 238-242 Genetic disorders, as cause of vocal cord
biology of, 239-241
paralysis, 137
in tissues, algorithm for identification of,
Genetic evaluation, and counseling, in
269, 272, 273-274
head and neck syndromes, 1159-1169
seen in vivo, presumptive characteriza-
in craniofacial disorders, 1160-1161
tion of, 269
Gianturco-Rosch stent, in major airway
taxonomy of, 241-242
collapse, 172
Gianturco stent, in major airway collapse,
171-172
Gait, abnormalities of, caused by central Gingivoperiosteoplasty, primary, in cleft
nervous system lesions, 647-650 palate, 1207
cautious, 649 Gliomas, brainstem, central vertigo in,
frontal, 649 596-598
lesions causing, topographic Glossopexy, in Pierre Robin sequence,
classification of, 643 1249-1250
psychogenic, 649 Glottic web, as cause of pediatric
quantification of, 650 dysphonia, 1117-1118
measures of, to assess outcome of dizzi- Glottis, anomalies of, 96-98
ness treatment, 527-528 stenosis of, posterior, botulinum toxin A
posture and, impact of age on, 650-653 in, 872
unsteadiness of, and unexplained falls, causes of, 856-857
assessment of, 637-657 classification of, 864, 865
examination of patient with, 643-646 due to gastroesophageal reflux, 859
examination of posture and gait in, due to iatrogenic trauma, 857-858
644 endoscopic surgery in, 866-869
neurologic examination in, 646 history of, based on causes, 857-861
Gait ignition failure syndrome, 644, 648 imaging studies in, 862-863
Gastroenterologic medications, dysphonia laryngeal electromyography in, 863
associated with, 775-776 laryngeal pacing in, 871
Gastroesophageal reflux, 785-787, 795 open surgery in, 870-871
and aspiration, in pediatric obstructive operative evaluation in, 863-864
sleep apnea syndrome, 55 pediatric, treatment of, 872
and laryngopharyngeal reflux, pediatric, physical examination in, 861-862
151-161 presentation of, 855-856
1404 CUMULATIVE INDEX 2000
Glottis (Continued) patient versus person with, 1373
pulmonary function tests in, 862 versus genetic disorder, 1372
surgical intervention in, indications Hearing loss, congenital, versus hereditary,
for, 866-871 1370-1373
surgical options in, 873-874 definition of, 1370-1373
treatment of, 865-866 genetics and molecular biology of, 1367-
Glottiscope, 1050-1051, 1052, 1053, 1054, 1394
1055 recent discoveries in, 1384-1387
Glottographic techniques, in dysphonia, in newborns and infants, otolaryngolo-
741-744 gists and, 1367-1370
Goldenhar’s syndrome, branchial nonsyndromic, and hearing impairment
apparatus anomalies in, 1328 syndromes, 1372, 1373-1374
Goodhill, Victor, MD, 8 of professional singers, 933
Goretex medialization, in paralytic vertigo and, 479-480
dysphonia, 851 vertigo and dysequilibrium with, 535-
Greig cephalopolysyndactyly, 1163 562
Growth impairment, in pediatric Heat, conservation of, during anesthesia,
obstructive sleep apnea syndrome, 55 31
Hemangioma(s), and vascular
malformations, of airway, 209-220
pediatric, incidence of, 209-210
Hallpike-Dix test, 568, 569
spontaneous involution of, 210, 213
Head and neck, anomalies of, genetic
treatment of, indications for, 210
evaluation and counseling in,
subglottic, 1182
1159-1169 pediatric, 98-101
neonatal care of infants with,
clinical presentation of, 210-211
1171-1189 evaluation of, 211-212
related to branchial apparatus,
expected outcome in, 213
1309-1332
management options in, 212-213
birth trauma to, 1176-1178
treatment of, 100-101
in cystic fibosis and ciliary dyskinesia,
Hematologic malignancies, prophylactic
1333-1342
antifungal agents in, 304-309
syndromic and other congenital anoma- Hemifacial microsomia, branchial
lies of, 1159-1388 apparatus anomalies in, 1328-1329
Head injury, closed, bilateral vocal fold
Hillyard, Victor, MD, 9
immobility in, 861 Histology laboratories, examination of
dizziness in, management of, 667 fungal rhinosinusitis specimens in,
Head position, as factor in voice 259-261
production, 1024 Histoplasmosis, sinusitis and, 264
Healy, Gerald, MD, 9, 10
Hearing impairment, hereditary, triazoles in, 288
Hoarseness. See Dysphonia(s).
audiologic testing in, 1380-1383 Holinger, Paul, MD, 9
classification of, 1370, 1377 Hooper, F.H., 806, 807
genetic testing in, 1387-1390 Hopkins, Harold H., PhD, 11
history taking in, 1387 Hormones, dysphonia associated with,
laboratory testing in, 1388 777-778
medical intervention in, 1389-1390 House, Howard, MD, 8
nonsyndromic, 1373, 1377-1380 Human papillomavirus, 1128-1129
penetrance, expressivity, and genetic Hyalohyphomyosis, sinusitis and, 266-268
heterogeniety in, 1375-1377 Hydrocephalus, and vascular white matter
physical examination in, 1387 disease, as cause of falls and gait
radiologic testing in, 1388 unsteadiness, 641
syndromic, 1372-1374, 1380-1383 normal pressure, 599
in abnormalities of mitochondrial DNA,
Hypochondria, dizziness in, 607
1375 Hypomandibulopexy, in Pierre Robin
in microtia atresia, 1353-1355 sequence, 1251
in velocardiofacial syndrome, 1225-1226 Hypothyroidism, in professional singers,
inheritance patterns of, 1374-1375 934
versus deafness, 1371
Hearing impairment syndrome(s), and
nonsyndromic hearing loss, 1372,
1373, 1380 Imbalance, definition of, 475